tagstash, the $2.25 capital raising at that stage was obviously too high and it caught out alot of people. The SP now IMO is very low and a great buying op. Investors dont seem to agree at this point in time although I am quite certain that the SP will start to move around early May.
In saying that VCR need to undertake many more implants in the UK and US where they recieve reimbursements, therefore revenue.
I dont think that the US trial will be finished by this month, more likely April/May, further enhancing the fundamentals for the company.
I do expect to see significant shareholders building on there stakes in the lead up to CE Mark approval and US BTT and DT trials.
VCR
ventracor limited
